UK\'s largest pharmaceutical company, Glaxo Smith Kline (GSK), is to eliminate up to 4K more jobs as part of its plans to reorganize and restructure its workforce and focus on developing markets. The bulk of the cuts will affect workers in the USA and Europe, and are part of the company's efforts to reshuffle resources away from low-growth expansive labor territories into parts of the world with greater scope to increase sales. read more at: http://business.timesonline.co.uk/tol/business/industry_sectors/health/article7009597.ece
Glaxo, which has been headed for nearly two years by chief executive Andrew Witty, employs 99,000 staff across the world and is expected to reveal plans for select cutbacks alongside its annual results this Thursday. This will be combined with a drive to make its research and development arm more cost-